中文名稱:化合物 AZ82 | 英文名稱:AZ82 |
CAS:1449578-65-7 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.31% | 產(chǎn)品類別: 抑制劑 |
貨號: T10428 |
Name | AZ82 |
Description | AZ82 is a selective and potent inhibitor of the kinesin-like protein KIFC1, inhibits KIFC1 expression in the cytoplasm and nucleus of PCa cells, and induces multipolar mitosis and apoptosis in prostate cancer cells. |
In vitro | AZ82 specifically induce multipolar spindles in BT-549 cells, but not in cancer cells with normal centrosome numbers, such as HeLa [1]. AZ82 binds specifically to KIFC1/MT complex but not to KIFC1 or MT alone. Treatment with AZ82 caused centrosome declustering in BT-549 breast cancer cells with amplified centrosomes. AZ82 inhibits both processes for mant-ATP binding/releasing (IC50: 0.90 μM/1.26 μM) [2]. |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 100 mg/mL (178.37 mM), Sonication is recommended. |
Keywords | AZ82 |
Inhibitors Related | 4-Isopropoxybenzoic acid | Mebendazole | Flubendazole | Oxfendazole | Methylene Blue | Thiabendazole | Methylene Blue trihydrate | N-Phenylbenzylamine | Paclitaxel | 4'-Demethylepipodophyllotoxin |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
青島愷潤生物醫(yī)藥科技有限公司
|
2025-01-18 | |
詢價 |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢價 |
VIP1年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-12-31 |